Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

Clinical trial NCT01217086 · COMPLETED

Trial details

NCT number: NCT01217086
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2010-10-01
Primary completion: 2011-11-01
Enrollment: 617

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.